IBC’s 3rd Annual Biosimilars Asia 2012 is the largest and most anticipated meeting of its kind in Asia. Attended by biosimilars, innovators, generics and biopharma alike, the unique mix of attendees from all over the world will share their experiences and opinions about the future of biosimilars. Tough questions will be answered and positions will be challenged but all will walk away bristling with ideas, opportunities and be more informed. Biosimilars Asia 2012 continues to deliver a quality of speakers and discussions unmatched in Asia.

REASONS WHY BIOSIMILARS ASIA IS A ‘MUST ATTEND’

• Biosimilars Asia 2012 is Asia’s LARGEST CONFERENCE addressing complex strategy questions, attended by regional and global innovators, generics, biopharma and biosimilars companies
• STRATEGIC PLENARY KEYNOTE SESSIONS with delegates from Biosimilars Asia 2012, China Pharmaceutical R&D Summit & Vaccines China 2012
• DON’T MISS OUT on ‘no-holds-barred’ discussions featuring innovators, generics, biosimilars and industry thoughtleaders!

由 IBC 主办的 2012年亚洲生物仿制药会议是亚洲地区同类会议中规模最大、参与程度最 高的一次盛会。来自世界各地的生物仿制药企业、创新机构、仿制药公司和生物制药企业 代表齐聚一堂，积极分享彼此的经验和对生物仿制药未来发展的看法。此次会议将深入探 讨众多棘手的问题，积极汇聚业界各方的观点，所有与会者必能带着更多资讯、见解和机 遇满载而归。2012年亚洲生物仿制药会议将沿袭以往的出色水准，汇聚亚洲地区最高级别 的与会者与畅所欲言的热烈讨论。

2012 年亚洲生物仿制药会议 “不容错过”的理由

• 2012年亚洲生物仿制药会议是亚洲地区致力于解决生物仿制药产 业复杂战略问题的最大规模会议，本地区乃至全球的创新机构、 仿制药企业、生物创新药和生物仿制药公司均会出席
• 出席2012年亚洲生物仿制药会议、中国药物研发峰会和 2012年中国疫苗会议的代表将共同出席战略性主题演讲
• 千万不要错过与创新机构、仿制药企业、生物仿制药公司和业 界思想领袖“无拘无束”探讨问题的机会！
• 聆听美国、欧盟、亚洲、和中东地区演讲者的精彩发言，了解关 于生物仿制药未来发展的全球观点
• 在同一地点结识众多亚洲和新兴医药市场生物仿制药公司代表

As world attention continues to shift towards Asia, increasing and ongoing investment into the pharmaceutical industry has come to fruition, matched by rapidly growing demand from the region. Funded by mostly private and emerging government supported initiatives, China is leading efforts as the future source of innovation and producer of quality medicines. Whether in new drug and vaccines discovery and development or in biosimilars, the time is ripe in China!

Pre-Conference Workshops:
US Market Entry: A Regulatory, Legal, and Medical Communication Perspective (Full Day)

Expression Systems for Antibody and Vaccine Biomanufacturing (Full Day)

US Market Entry: A Regulatory, Legal, and Medical Communication Perspective

Expression Systems for Antibody and Vaccine Biomanufacturing

Meet the Speakers Reception (by Invitation only)

China Pharma R&D, Vaccines & Biosimilars

JOINT PLENARY SESSION

Global and Regional Keynote Presentations
On Pharma R&D

Post-Conference Workshops:
Next Generation of Vaccine Facilities
with Focus on Design & Containment

Turning Strategies into Tactical
Plans to Optimize Market Entry –
Balancing Commercial, Regulatory
and Investments to Deliver Successful
Business Models